Aardvark Therapeutics Inc. Common Stock (AARD)
Stock · NASDAQ · Health Care
$5.79as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$5.32
Industry
Biotechnology: Pharmaceutical Preparations
About AARD
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 28
- Website
- aardvarktherapeutics.com/
Fundamentals
- 1-day range
- $5.62$6.47
- Market cap
- $154.94M
- P/E (trailing)
- —
- P/E (forward)
- -2.08
- EPS (trailing)
- $-3.21
- Dividend yield
- —
- Beta
- 3.84
- Avg. volume
- 252.8K
52-week range
$3.35$17.94
Next earnings: November 12, 2026 · EPS estimate $-0.77confirmed
Forecasts
10 analyst ratings
Buy 61%
Hold 28%
Sell 11%
1-year price forecast
High
$45
+677.2%
Median
$6.5
+12.3%
Low
$3
-48.2%
Aardvark Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AARDAardvark Therapeutics Inc. Common Stock$5.71▼ 13.75%Market cap $154.94MP/E —$3.35$17.94
- KRROKorro Bio Inc. Common Stock$12.94▼ 2.41%Market cap $154.90MP/E —$5.2$55.89
- CNTNCanton Strategic Holdings Inc. Common Stock$2.23▼ 5.32%Market cap $154.25MP/E —$1.75$7.25
- MENSJyong Biotech Ltd. Ordinary Shares$2.37▲ 3.04%Market cap $152.06MP/E —$1.43$67
- OKUROnKure Therapeutics Inc. Class A Common Stock$3.78▼ 1.31%Market cap $162.39MP/E —$2.23$5.38
- LFCRLifecore Biomedical Inc. Common Stock$4.58▲ 0.88%Market cap $164.67MP/E —$3.63$8.98
- KZIAKazia Therapeutics Limited American Depositary Shares$13.59▼ 19.59%Market cap $141.81MP/E —$4.86$17.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AARD Aardvark Therapeutics Inc. Common Stock | $154.94M | — | $5.71 | ▼ 13.75% | $3.35$17.94 |
| KRRO Korro Bio Inc. Common Stock | $154.90M | — | $12.94 | ▼ 2.41% | $5.2$55.89 |
| CNTN Canton Strategic Holdings Inc. Common Stock | $154.25M | — | $2.23 | ▼ 5.32% | $1.75$7.25 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $152.06M | — | $2.37 | ▲ 3.04% | $1.43$67 |
| OKUR OnKure Therapeutics Inc. Class A Common Stock | $162.39M | — | $3.78 | ▼ 1.31% | $2.23$5.38 |
| LFCR Lifecore Biomedical Inc. Common Stock | $164.67M | — | $4.58 | ▲ 0.88% | $3.63$8.98 |
| KZIA Kazia Therapeutics Limited American Depositary Shares | $141.81M | — | $13.59 | ▼ 19.59% | $4.86$17.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 8/28/2026
- Aardvark Therapeutics Inc (AARD) (Q2 2026) Earnings Call Highlights: Board Re-Elected, Auditor ...Yahoo · 8/17/2026
- Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business UpdatesYahoo · 8/11/2026
- Aardvark Therapeutics Q2 EPS $(0.66) Beats $(0.91) EstimateBenzinga · 8/11/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 10.10M
- Total value held
- $37.98M
- Institutional holders
- 76
Top holders this quarter
- Unknown3.92M
- Unknown1.30M
- Unknown1.03M
- Unknown792.6K
- Unknown554.1K
- Unknown316.6K
- Unknown309.4K
- Unknown300.0K
- Unknown199.3K
- Unknown163.4K
See the full, filterable feed with live charts on the MarketWall dashboard.